Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.2K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

80
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
80
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.9K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.3K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

40
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
40

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

LMSCDA: A Secondary Structure Enhanced Language Model for Predicting CircRNA and Disease Associations.

IEEE journal of biomedical and health informatics·2026
Same author

Integrating Transformer and Graph Attention Network for circRNA-miRNA Interaction Prediction.

IEEE journal of biomedical and health informatics·2025
Same author

A heterogeneous information network learning model with neighborhood-level structural representation for predicting lncRNA-miRNA interactions.

Computational and structural biotechnology journal·2025
Same author

Motif-Aware miRNA-Disease Association Prediction via Hierarchical Attention Network.

IEEE journal of biomedical and health informatics·2024
Same author

Biolinguistic graph fusion model for circRNA-miRNA association prediction.

Briefings in bioinformatics·2024
Same author

Likelihood-based feature representation learning combined with neighborhood information for predicting circRNA-miRNA associations.

Briefings in bioinformatics·2024

相关实验视频

Updated: Feb 26, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

通过双重聚合和协作优化进行药物相互作用预测的多关系知识图.

Yu Wei1, Meng-Meng Wei2, Bo-Wei Zhao3

  • 1Guangxi Key Lab of Human-machine Interaction and Intelligent Decision, Guangxi Academy of Sciences, Nanning 530007, China; School of Computer Science, Northwestern Polytechnical University, Xi'an 710129, China.

Bioorganic chemistry
|February 24, 2026
PubMed
概括

一个新的框架,MRACO,通过高效地处理知识图中的复杂数据来改善药物相互作用 (DDI) 的预测. 这种方法提高了对药物相互作用的理解,以实现更安全的临床使用和开发.

关键词:
深度学习是一种深度学习.药物相互作用 药物相互作用高级邻里信息 高级邻里信息链接预测链接预测关系图卷积网络的关系图.

更多相关视频

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K

相关实验视频

Last Updated: Feb 26, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K

科学领域:

  • 计算化学是一种计算化学.
  • 药理学 药理学是指药理学的学科.
  • 生物信息学是一种生物信息学.

背景情况:

  • 药物相互作用 (DDI) 在临床实践和药物开发中至关重要,存在不良反应的风险.
  • 计算方法越来越多地用于DDI预测,但面临复杂性和异质信息的挑战.
  • 现有的模型经常在节点特征表示和捕捉实体交互性和多语法方面扎.

研究的目的:

  • 提出一个新的框架,MRACO (多关系双重聚合和协作优化),用于准确的DDI预测.
  • 解决现有计算方法在处理知识图中复杂,异质信息方面的局限性.
  • 提高DDI预测模型的效率和稳定性.

主要方法:

  • 开发了一种使用多关系知识图的双重聚合和协作优化学习框架 (MRACO).
  • 采用双重聚合操作来编码和聚合多种类型的信息,捕捉药物节点的各种语义关系.
  • 利用协作损失优化功能来简化计算,减少冗余,并提高模型的稳定性.

主要成果:

  • MRACO有效地利用来自多关系知识图的结构信息来学习跨关系类型的交互性.
  • 该框架在多关系网络中展示了强大的特征提取能力.
  • 实验证实了MRACO对DDI潜在机制的增强理解,从而提高了预测稳定性.

结论:

  • 通过利用知识图结构和高级学习技术,MRACO为DDI预测提供了有效的解决方案.
  • 拟议的框架克服了当前DDI预测模型中的计算复杂性和信息异质性挑战.
  • MRACO集成深层次交互信息的能力提高了预测的准确性和稳定性,有助于更安全的药物开发和临床应用.